Month of Kidney Cancer Awareness
The most prevalent cancers are represented by the following colors:
- White Lung Cancer
- gray brain cancer
- Pink breast cancer
- Emerald-green liver cancer
- Lime green: lymphoma
- Cancer of the prostate: pale blue
- Cancer of the stomach: periwinkle blue
- the color yellow
- Dark blue: colon cancer
However, there are still more on the list, and some tumors even have a common color. The color orange stands for leukemia and kidney cancer. Green denotes cancers of the liver, lymphoma, and gallbladder. Purple hues stand for esophageal, stomach, testicular, leiomyosarcoma, pancreatic, and Hodgkin lymphoma cancers.
Some advocates believe that this tsunami of wristbands, keychains, and coffee cups that resembles tie-dye may further muddle the focus on certain illnesses.
Think about prostate and colorectal cancer. Brown ribbons were originally worn by supporters of colorectal cancer until they transitioned to dark blue. While doing so, those promoting awareness of prostate cancer employ light blue The Prostate Cancer Foundation publishes the precise mathematical formula for a shade that is so accurate.
Thomas N. Kirk, president and CEO of Us TOO, which offers educational materials, services, and 300 volunteer-led support groups for persons with prostate cancer, said throughout the years that marketing experts have told him that the blue is confusing to people because they don’t know what it represents.
According to Kirk, the light blue hue associated with prostate cancer and the teal color of ovarian cancer are quite similar. Prostate cancer and ovarian cancer share the same (awareness) month when buildings are lit up in September. Many times, when individuals notice a blue color, they assume it is either prostate cancer or ovarian cancer.
In This Article...
Green, purple, or red?
There are also certain types of blood malignancies. According to a group called the Lymphoma Club, lime green was adopted as the official color to support all lymphoma causes in 1999, and in 2001, Hodgkin lymphoma patient Matt Terry chose violet to symbolize his particular disease. In order to recognize all types of lymphoma, survivors of those illnesses combined the two hues in 2007, according to club members, into an awareness heart ribbon. However, the Leukemia & Lymphoma Society started using red to symbolize all blood malignancies in 2009.
According to Andrea Greif, senior director of communications for the Leukemia & Lymphoma Society, there has never really been unanimity about which hue should symbolize which disease across the board and across many organizations.
… You’ll likely discover that several organizations use different colors to represent the same diseases; some could use green for lymphoma and gold for leukemia. Greif included in a message. We decided to stick with red for all types of blood cancer.
Gold, too? According to the American Childhood Cancer Organization, gold is a priceless medal and is thus the ideal hue to depict the most precious thing in our livesour children. It has also been used as a symbol for all childhood malignancies since 1997.
According to a USPTO representative, cancer advocacy organizations are not required to register their colors with the agency.
Some of these additional hues came from where and how? The techniques range from the warmth of a dining room to the formality of a boardroom.
Color theory
The Kidney Cancer Association changed from Kelly green, which at the time signified illnesses of the internal organs, as a result of color theory study done in 2005. According to the data, orange was a superior hue, and consumer testing confirmed this, according to Bill Bro, the association’s CEO and a cancer survivor. It aids in setting us apart from other, smaller charities that also have a similar purpose. They frequently stick to the color green.
A month for kidney cancer?
National Kidney Cancer Awareness Month is in March. March is a fantastic time to get involved and start campaigning if you or someone you know has been affected by this illness, which is one of the ten malignancies that afflict men and women most frequently in the United States.
All Americans are urged to check on their kidney health during Kidney Cancer Awareness Month, which includes getting a kidney screening and talking to your doctor about your risk.
Does March serve as Kidney Cancer Awareness Month?
Since March is National Kidney Cancer Awareness Month, it’s a great opportunity to draw attention to these remarkable organs, which serve in many ways as janitors. They eliminate medications and trash from the body, balance fluids, release hormones that control blood pressure, and do so much more. However, if any one of these dynamic duos stops functioning, it can cause serious health issues.
One of the top 10 malignancies that affect both men and women is kidney cancer. About 79,000 additional cases of kidney cancer will be identified in 2022. Kidney cancer can affect anyone, even though most incidences tend to be in those over 45 and are more common in men.
It is essential that kidney cancer treatment be tailored to the patient because kidney cancer can affect everyone and has a range of severity. With consideration for each patient’s age, general health, life expectancy, and tumor features, urologists, medical oncologists, and radiation oncologists at UF Health collaborate to create tailored, multidisciplinary treatment programs.
“Access to multi-modal therapy is crucial for patients with locally advanced and metastatic disease. We can customize treatment plans for specific patients in order to optimize their cancer care and maintain or improve their quality of life. According to Padriac O’Malley, MD, MSc, FRCSC, assistant professor in the department of urology at the University of Florida College of Medicine, it is a major focus of what we do at UF Health Urology.
Options may include surgery, such as a radical or partial nephrectomy, to surveillance or thermal ablation for cancers that have not spread from the tissue or organ in which they originated. Options for treating advanced tumors can also include surgery, systemic medication like immunotherapy, or a combination of the two. Multidisciplinary surgical teams are a part of UF Health’s team-based approach to kidney cancer treatment for patients who may have extremely complex tumors affecting the heart or liver. On the side of radiation oncology, radiation treatment plans are being designed to act with the surgical level of accuracy and minimal invasiveness.
“Li-Ming Su, MD, the chair of the department of urology, stated that we are incredibly lucky to have expertise in every facet of kidney cancer treatment at UF Health.
How long will kidney cancer patients live?
For various kidney cancer stages, there are no statistics available for the entire United Kingdom.
For each stage of kidney cancer, survival statistics are provided in one region of England. Men and women diagnosed between 2013 and 2017 are included in these statistics.
The definition of National Kidney Month
The understanding, management, and prevention of kidney disorders are being changed by NIDDK research. In order to better care for renal patients, researchers are focusing on developing new medicines that are specific to each patient’s illness type, environment, and lifestyle. Find out more about the NIDDK’s research on kidney disease.
What is the average age of kidney cancer diagnosis?
- There will be 50,290 new instances of kidney cancer in males and 28,710 in women, totaling almost 79,000 new cases.
- Around 13,920 people will pass away from this illness, including 8,960 males and 4,960 women.
The majority of kidney cancer patients are elderly. The majority of persons are diagnosed between the ages of 65 and 74, with an average diagnosis age of 64. When a person is under the age of 45, kidney cancer is quite rare.
Males are more likely to develop kidney cancer than females are, and it affects African Americans and American Indians/Alaska Natives more frequently.
Renal cell carcinoma
The most typical form of kidney cancer is renal cell carcinoma (RCC), sometimes referred to as renal cell cancer or renal cell adenocarcinoma. Renal cell carcinomas make up about 90% of kidney cancer cases.
Although RCC often develops as a single tumor inside the kidney, there may occasionally be two or more tumors there, or even tumors in both kidneys at once.
RCC has a number of subgroups, primarily determined by how the cancer cells appear in the laboratory. Knowing the subtype of RCC can assist your doctor decide on a course of treatment and establish whether your cancer may have been caused by an inherited genetic condition. For further details on inherited kidney cancer syndromes, see Risk Factors for Kidney Cancer.
Clear cell renal cell carcinoma
The most typical type of renal cell carcinoma is this one. This type of cancer affects almost seven out of ten RCC patients. The cells that make up clear cell RCC seem exceedingly pale or clear when seen in the lab.
Non-clear cell renal cell carcinomas
About 1 in 10 cases of renal cell carcinoma are of the second most prevalent subtype, papillary. Some of these cancers’ tumors, if not the majority of them, develop tiny fingerlike projections known as papillae. These malignancies are sometimes referred to as chromophilic cancers because the cells absorb specific dyes and appear pink when observed under a microscope.
Renal cell carcinoma with chromophobes: This subtype makes up around 5% (5 instances per 100). Similar to the clear cells, these tumors also have pale cells, but they are larger and have additional characteristics that can be identified when viewed in great detail.
Renal cell carcinomas that are uncommon: Each of these subtypes is extremely uncommon, accounting for fewer than 1% of RCCs.
- RCC collecting duct
- Multiple-locular RCC
- Middle-brain cancer
- Spindle cell and mucin-filled tubular carcinoma
- RCC linked to neuroblastoma
Rarely, renal cell carcinomas are given the classification “unclassified” because of their appearance, which doesn’t fall under any of the other categories, or because more than one type of cancer cell is present.
Other types of kidney cancers
Transitional cell carcinomas, Wilms tumors, and renal sarcomas are other varieties of kidney cancer.
Transitional cell carcinoma: Also known as urothelial carcinomas, transitional cell carcinomas (TCCs) account for 510 of every 100 kidney malignancies.
The lining of the renal pelvis, not the kidney itself, is where transitional cell carcinomas begin (where the ureters meet the kidneys). Transitional cells, which resemble the cells that line the ureters and bladder, make up this lining. When closely examined in the laboratory, cancers that arise from these cells resemble other urothelial carcinomas, such as bladder cancer. Similar to bladder cancer, these malignancies are frequently connected to cigarette smoking and occupational exposure to specific cancer-causing substances.
Blood in the urine and occasionally back discomfort are common symptoms shared by persons with TCC and renal cell carcinoma.
Nephroblastoma, often known as the Wilms tumor, almost always affects youngsters. In adults, this kind of cancer is quite uncommon. See Wilms Tumor for additional information about this type of cancer.
Renal sarcomas are a rare form of kidney cancer that start in the kidney’s blood vessels or connective tissue. They account for fewer than 1% of all kidney cancer cases.
What signs might kidney cancer have?
Larger kidney malignancies may present with signs and symptoms, while smaller ones typically don’t. Following are some potential indicators and symptoms of kidney cancer:
- Urine with blood in it (hematuria)
- One side of the low back hurts (not caused by injury)
- a bulge on the lower back or side
- Fatigue (tiredness)
- Dieting does not lead to weight loss
- Fever that does not stem from an illness and does not subside
- Anemia (low red blood cell counts)
Although kidney cancer (or another type of cancer) might induce these symptoms, other, benign disorders are more frequently at blame. For instance, a kidney stone or a bladder or urinary tract infection are the most typical causes of blood in the urine. However, if you have any of these signs, you should consult a doctor so that the cause can be identified and, if necessary, addressed.
